aspartame and Metabolic Diseases

aspartame has been researched along with Metabolic Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahamad, N; Anand, BG; Dubey, K; Joseph, GK; Kar, K; Prajapati, KP; Rath, PC; Shekhawat, DS1
Araújo, JR; Keating, E; Martel, F1
Astrup, A; Belza, A; Chabanova, E; Maersk, M; Pedersen, SB; Richelsen, B; Ringgaard, S; Stødkilde-Jørgensen, H; Thomsen, H1

Reviews

1 review(s) available for aspartame and Metabolic Diseases

ArticleYear
Exposure to non-nutritive sweeteners during pregnancy and lactation: Impact in programming of metabolic diseases in the progeny later in life.
    Reproductive toxicology (Elmsford, N.Y.), 2014, Volume: 49

    Topics: Aspartame; Female; Humans; Lactation; Male; Metabolic Diseases; Non-Nutritive Sweeteners; Pregnancy; Prenatal Exposure Delayed Effects

2014

Trials

1 trial(s) available for aspartame and Metabolic Diseases

ArticleYear
Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study.
    The American journal of clinical nutrition, 2012, Volume: 95, Issue:2

    Topics: Absorptiometry, Photon; Adult; Animals; Aspartame; Beverages; Blood Pressure; Body Fat Distribution; Cardiovascular Diseases; Cholesterol; Dietary Sucrose; Energy Intake; Female; Humans; Intra-Abdominal Fat; Lipid Metabolism; Liver; Magnetic Resonance Spectroscopy; Male; Metabolic Diseases; Middle Aged; Milk; Muscle, Skeletal; Obesity; Outcome Assessment, Health Care; Sweetening Agents; Time; Triglycerides

2012

Other Studies

1 other study(ies) available for aspartame and Metabolic Diseases

ArticleYear
Self-Assembly of Artificial Sweetener Aspartame Yields Amyloid-like Cytotoxic Nanostructures.
    ACS nano, 2019, 05-28, Volume: 13, Issue:5

    Topics: Amyloid; Amyloid beta-Peptides; Aspartame; Cell Proliferation; Hemolysis; Humans; Hydrophobic and Hydrophilic Interactions; Metabolic Diseases; Nanofibers; Nanostructures; Protein Conformation, beta-Strand; Sweetening Agents

2019